Nirenberg Melissa J, Waters Cheryl
Division of Movement Disorders, Department of Neurology, Columbia University Medical Center, New York, NY 10021, USA.
Mov Disord. 2006 Apr;21(4):524-9. doi: 10.1002/mds.20757.
Dopamine agonists have been implicated in causing compulsive behaviors in patients with Parkinson's disease (PD). These have included gambling, hypersexuality, hobbyism, and other repetitive, purposeless behaviors ("punding"). In this report, we describe 7 patients in whom compulsive eating developed in the context of pramipexole use. All of the affected patients had significant, undesired weight gain; 4 had other comorbid compulsive behaviors. In the 5 patients who lowered the dose of pramipexole or discontinued dopamine agonist treatment, the behavior remitted and no further weight gain occurred. Physicians should be aware that compulsive eating resulting in significant weight gain may occur in PD as a side-effect of dopamine agonist medications such as pramipexole. Given the known risks of the associated weight gain and obesity, further investigation is warranted.
多巴胺激动剂被认为会导致帕金森病(PD)患者出现强迫行为。这些行为包括赌博、性欲亢进、沉溺于某种嗜好以及其他重复性、无目的的行为(“刻板行为”)。在本报告中,我们描述了7例在使用普拉克索的情况下出现强迫性进食的患者。所有受影响的患者体重均显著增加且不理想;4例还伴有其他共病性强迫行为。在5例降低普拉克索剂量或停止多巴胺激动剂治疗的患者中,该行为缓解,体重未再进一步增加。医生应意识到,作为普拉克索等多巴胺激动剂药物的副作用,PD患者可能会出现导致体重显著增加的强迫性进食。鉴于已知的体重增加和肥胖相关风险,有必要进行进一步研究。